365 related articles for article (PubMed ID: 2445559)
1. Abnormal B-cell function in neonatally streptozotocin-diabetic rats: insensitivity to alloxan toxicity.
Grill V; Westberg M
Endocrinology; 1987 Dec; 121(6):2171-6. PubMed ID: 2445559
[TBL] [Abstract][Full Text] [Related]
2. Multiple abnormalities in insulin responses to nonglucose nutrients in neonatally streptozotocin diabetic rats.
Grill V; Sako Y; Ostenson CG; Jalkanen P
Endocrinology; 1991 Apr; 128(4):2195-203. PubMed ID: 1706269
[TBL] [Abstract][Full Text] [Related]
3. Selective impairment of pancreatic A cell suppression by glucose during acute alloxan-induced insulinopenia: in vitro study on isolated perfused rat pancreas.
Filipponi P; Gregorio F; Cristallini S; Ferrandina C; Nicoletti I; Santeusanio F
Endocrinology; 1986 Jul; 119(1):408-15. PubMed ID: 3522213
[TBL] [Abstract][Full Text] [Related]
4. B cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia.
Grill V; Westberg M; Ostenson CG
J Clin Invest; 1987 Sep; 80(3):664-9. PubMed ID: 2442195
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands.
Grill V; Rundfeldt M
Diabetes; 1986 Jan; 35(1):44-51. PubMed ID: 2416619
[TBL] [Abstract][Full Text] [Related]
6. Loss of a priming effect of glucose on A and D cell secretion in perfused pancreases from alloxan-diabetic rats: role of insulin and alloxan.
Grill V; Efendić S
Diabetologia; 1983 Jan; 24(1):47-51. PubMed ID: 6131006
[TBL] [Abstract][Full Text] [Related]
7. Abnormal D cell secretion in alloxan-diabetes: influence by drug and aberrant metabolism.
Grill V; Efendić S
Am J Physiol; 1984 Jun; 246(6 Pt 1):E483-92. PubMed ID: 6204535
[TBL] [Abstract][Full Text] [Related]
8. Abnormal regulation by glucose of somatostatin secretion in the perfused pancreas of NIDDM rats.
Ostenson CG; Efendic S; Grill V
Pancreas; 1990 May; 5(3):347-53. PubMed ID: 1971441
[TBL] [Abstract][Full Text] [Related]
9. Concanavalin A and alloxan interactions on glucose-induced insulin secretion and biosynthesis from islets of Langerhans.
Virji MA; Steffes MW; Estensen RD
Diabetes; 1984 Feb; 33(2):164-9. PubMed ID: 6363170
[TBL] [Abstract][Full Text] [Related]
10. Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass.
Leahy JL; Bonner-Weir S; Weir GC
Diabetes; 1984 Jul; 33(7):667-73. PubMed ID: 6203798
[TBL] [Abstract][Full Text] [Related]
11. Irreversible loss of normal beta-cell regulation by glucose in neonatally streptozotocin diabetic rats.
Inoue K; Cetkovic-Cvrlje M; Eizirik DL; Grill V
Diabetologia; 1994 Apr; 37(4):351-7. PubMed ID: 8063034
[TBL] [Abstract][Full Text] [Related]
12. Abnormal insulin secretion in a streptozocin model of diabetes. Effects of insulin treatment.
Leahy JL; Bonner-Weir S; Weir GC
Diabetes; 1985 Jul; 34(7):660-6. PubMed ID: 2408948
[TBL] [Abstract][Full Text] [Related]
13. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
Serradas P; Bailbé D; Portha B
Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
[TBL] [Abstract][Full Text] [Related]
14. Modulation by alloxan of glucagon and insulin secretion in the isolated perfused rat pancreas.
Goto Y; Seino Y; Taminato T; Inoue Y; Kadowaki S; Mori K; Imura H
Endocrinology; 1978 May; 102(5):1496-500. PubMed ID: 369831
[TBL] [Abstract][Full Text] [Related]
15. Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats.
Pagliara AS; Stillings SN; Haymond MW; Hover BA; Matschinsky FM
J Clin Invest; 1975 Feb; 55(2):244-55. PubMed ID: 123928
[TBL] [Abstract][Full Text] [Related]
16. Diazoxide infusion at excess but not at basal hyperglycemia enhances beta-cell sensitivity to glucose in vitro in neonatally streptozotocin-diabetic rats.
Sako Y; Grill VE
Metabolism; 1992 Jul; 41(7):738-43. PubMed ID: 1535679
[TBL] [Abstract][Full Text] [Related]
17. Decreased glucose-induced cAMP and insulin release in islets of diabetic rats: reversal by IBMX, glucagon, GIP.
Dachicourt N; Serradas P; Giroix MH; Gangnerau MN; Portha B
Am J Physiol; 1996 Oct; 271(4 Pt 1):E725-32. PubMed ID: 8897861
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic effects of alloxan treatment in vitro on monolayer cultures of neonatal rat pancreas.
Gorray KC; Baskin DG; Fujimoto WY
Am J Physiol; 1983 Oct; 245(4):E417-23. PubMed ID: 6353938
[TBL] [Abstract][Full Text] [Related]
19. Release of catecholamines is increased but does not contribute to the impaired insulin secretion in the perfused pancreata of diabetic rats.
Ostenson CG; Hjemdahl P; Efendic S
Pancreas; 1993 Jan; 8(1):34-8. PubMed ID: 8419906
[TBL] [Abstract][Full Text] [Related]
20. Regulation of alpha-cell function by the beta-cell in isolated human and rat islets deprived of glucose: the "switch-off" hypothesis.
Hope KM; Tran PO; Zhou H; Oseid E; Leroy E; Robertson RP
Diabetes; 2004 Jun; 53(6):1488-95. PubMed ID: 15161753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
